ProKidney to acquire two Winston-Salem buildings for $22.5M for rilparencel manufacturing

PROKIDNEY CORP.

Purchase price of $22.5 million in cash for two buildings totaling ~180,000 sq ft.
Buildings will support manufacturing operations for lead product candidate rilparencel.
Transaction expected to close by end of November 2024, subject to customary conditions.
Company currently occupies portions of the buildings under existing leases.
Agreement contains customary representations; no financing contingency disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.